BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 33953549)

  • 1. Age-Related Clinical Outcomes of Patients with Non-Valvular Atrial Fibrillation: Insights from the COOL-AF Registry.
    Krittayaphong R; Boonyapiphat T; Wongvipaporn C; Sairat P;
    Clin Interv Aging; 2021; 16():707-719. PubMed ID: 33953549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of gender on the clinical outcomes of Asian non-valvular atrial fibrillation patients: insights from the prospective multicentre COOL-AF registry.
    Krittayaphong R; Phrommintikul A; Winijkul A; Methavigul K; Komoltri C; Kaewkumdee P; Yindeengam A;
    BMJ Open; 2021 May; 11(5):e043862. PubMed ID: 33958338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of anemia on clinical outcomes of patients with atrial fibrillation: The COOL-AF registry.
    Krittayaphong R; Pumprueg S; Thongsri T; Wiwatworapan W; Choochunklin T; Kaewkumdee P; Yindeengam A;
    Clin Cardiol; 2021 Mar; 44(3):415-423. PubMed ID: 33538035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence to Anticoagulant Guideline for Atrial Fibrillation Improves Outcomes in Asian Population: The COOL-AF Registry.
    Krittayaphong R; Winijkul A; Kunjara-Na-Ayudhya R; Apiyasawat S; Siriwattana K; Kanjanarutjawiwat W; Dutsadeevettakul S; Lip GYH;
    Stroke; 2020 Jun; 51(6):1772-1780. PubMed ID: 32390554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How do anticoagulated atrial fibrillation patients who suffer ischemic stroke or spontaneous intracerebral hemorrhage differ?
    Lehtola H; Hartikainen J; Hartikainen P; Kiviniemi T; Nuotio I; Palomäki A; Ylitalo A; Airaksinen KEJ; Mustonen P
    Clin Cardiol; 2018 May; 41(5):608-614. PubMed ID: 29745996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of patients with atrial fibrillation with and without diabetes: A propensity score matching of the COOL-AF registry.
    Krittayaphong R; Aroonsiriwattana S; Ngamjanyaporn P; Patmuk T; Kaewkumdee P;
    Int J Clin Pract; 2021 Nov; 75(11):e14671. PubMed ID: 34324768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral anticoagulation and cardiovascular outcomes in patients with atrial fibrillation and chronic kidney disease in Asian Population, Data from the COOL-AF Thailand registry.
    Chantrarat T; Krittayaphong R
    Int J Cardiol; 2021 Jan; 323():90-99. PubMed ID: 32828960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Status and Clinical Outcomes of Oral Anticoagulant Discontinuation After Ablation for Atrial Fibrillation in Japan - Findings From the AF Frontier Ablation Registry.
    Okumura Y; Nagashima K; Arai M; Watanabe R; Yokoyama K; Matsumoto N; Otsuka T; Suzuki S; Hirata A; Murakami M; Takami M; Kimura M; Fukaya H; Nakahara S; Kato T; Shimizu W; Iwasaki YK; Hayashi H; Harada T; Nakajima I; Okumura K; Koyama J; Tokuda M; Yamane T; Momiyama Y; Tanimoto K; Soejima K; Nonoguchi N; Ejima K; Hagiwara N; Harada M; Sonoda K; Inoue M; Kumagai K; Hayashi H; Satomi K; Yazaki Y; Watari Y;
    Circ J; 2019 Nov; 83(12):2418-2427. PubMed ID: 31619591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Average Systolic Blood Pressure and Clinical Outcomes in Patients with Atrial Fibrillation: Prospective Data from COOL-AF Registry.
    Krittayaphong R; Pumprueg S; Ratanasumawong K; Sairat P; Lip GYH;
    Clin Interv Aging; 2021; 16():1835-1846. PubMed ID: 34675498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF).
    Rohla M; Weiss TW; Pecen L; Patti G; Siller-Matula JM; Schnabel RB; Schilling R; Kotecha D; Lucerna M; Huber K; De Caterina R; Kirchhof P
    BMJ Open; 2019 Mar; 9(3):e022478. PubMed ID: 30928922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with low health-related quality of life among younger and older Thai patients with non-valvular atrial fibrillation.
    Srinonprasert V; Ratanasumawong K; Thongsri T; Dutsadeevettakul S; Jittham P; Wiwatworapan W; Krittayaphong R;
    Qual Life Res; 2019 Aug; 28(8):2091-2098. PubMed ID: 30953293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline Characteristics of Elderly Japanese Patients Aged ≥75 Years With Non-Valvular Atrial Fibrillation and a History of Stroke - ANAFIE Registry.
    Kanemaru K; Yoshimoto T; Inoue H; Yamashita T; Akao M; Atarashi H; Ikeda T; Okumura K; Koretsune Y; Shimizu W; Tsutsui H; Hirayama A; Yasaka M; Yamaguchi T; Teramukai S; Kimura T; Kaburagi J; Takita A; Kusano K; Toyoda K;
    Circ J; 2020 Feb; 84(3):516-523. PubMed ID: 31983727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Rate of Clinical Outcomes in Atrial Fibrillation according to Antithrombotic Strategy: The COOL-AF Registry.
    Krittayaphong R; Winijkul A; Methavigul K; Sairat P; Investigators COOLF
    Cardiovasc Ther; 2022; 2022():5797257. PubMed ID: 35284003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary Prevention of Stroke with Warfarin in Patients with Nonvalvular Atrial Fibrillation: Subanalysis of the J-RHYTHM Registry.
    Kodani E; Atarashi H; Inoue H; Okumura K; Yamashita T; Origasa H;
    J Stroke Cerebrovasc Dis; 2016 Mar; 25(3):585-99. PubMed ID: 26725259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent vascular events in patients with ischemic stroke/TIA and atrial fibrillation in relation to secondary prevention at hospital discharge.
    Tentschert S; Parigger S; Dorda V; Bittner K; Unterbuchschachner D; Greisenegger S; Wimmer R; Brücke T; Lang W; Lalouschek W;
    Wien Klin Wochenschr; 2004 Dec; 116(24):834-8. PubMed ID: 15690967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Nonagenarians With Atrial Fibrillation: Insights From the Berlin Atrial Fibrillation (BAF) Registry.
    Wutzler A; von Ulmenstein S; Attanasio P; Huemer M; Parwani AS; Boldt LH; Haverkamp W
    J Am Med Dir Assoc; 2015 Nov; 16(11):969-72. PubMed ID: 26123257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reasons for and consequences of oral anticoagulant underuse in atrial fibrillation with heart failure.
    Savarese G; Sartipy U; Friberg L; Dahlström U; Lund LH
    Heart; 2018 Jul; 104(13):1093-1100. PubMed ID: 29371374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors for Stroke and Death in Non-Anticoagulated Asian Patients with Atrial Fibrillation: The Fushimi AF Registry.
    Hamatani Y; Yamashita Y; Esato M; Chun YH; Tsuji H; Wada H; Hasegawa K; Abe M; Lip GY; Akao M
    PLoS One; 2015; 10(11):e0142394. PubMed ID: 26540107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and safety of rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation and heart failure.
    Martinez BK; Bunz TJ; Eriksson D; Meinecke AK; Sood NA; Coleman CI
    ESC Heart Fail; 2019 Feb; 6(1):10-15. PubMed ID: 30299591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-Year Outcomes of Anticoagulation for Acute Ischemic Stroke With Nonvalvular Atrial Fibrillation - SAMURAI-NVAF Study.
    Yoshimura S; Koga M; Sato S; Todo K; Yamagami H; Kumamoto M; Itabashi R; Terasaki T; Kimura K; Yagita Y; Shiokawa Y; Kamiyama K; Okuda S; Okada Y; Takizawa S; Hasegawa Y; Kameda T; Shibuya S; Nagakane Y; Ito Y; Matsuoka H; Takamatsu K; Nishiyama K; Fujita K; Kamimura T; Ando D; Ide T; Yoshimoto T; Shiozawa M; Matsubara S; Yamaguchi Y; Kinoshita N; Matsuki T; Takasugi J; Tokunaga K; Higashida K; Homma K; Kario K; Arihiro S; Toyoda K;
    Circ J; 2018 Jun; 82(7):1935-1942. PubMed ID: 29863095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.